Other Transaction Agreement HR00111590014

Award Date 9/23/15
Potential Completion Date 12/22/20
Potential Value $25M
Contracting Federal Agency
Defense Contract Management Agency
Ultimate Awardee
Not listed
NAICS Category
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed
Major Defense Program
Not listed
Pricing Type
Other
Place of Performance
Oakland, CA 94608, USA
Solicitation Procedures
Broad Agency Announcement
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $4,797,261 definitive contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Ginkgo Bioworks, Inc., a biotechnology company based in Boston. The contract is for DARPA's "SUPERB: SYNBIO + UNIVERSAL PURIFICATION OF EXTRACT-DERIVED, RIGHT-ON-TIME BIOLOGICS" program, which aims to develop technologies enabling immediate synthesis of bioactive protein medical countermeasures and production enzymes within 24 hours at a yield of at least 500 doses per week....
This is a $225,000.00 Firm Fixed Price contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Technology Holding LLC, a small, for-profit limited liability company specializing in research and development services. The contract is part of DARPA's Small Business Innovation Research (SBIR) program and is for Phase I of an effort titled "AUTONOMOUS BIOMANUFACTORING AT REMOTE LOCATIONS". The contract has a total small business set-aside and supports the development of...
<p>This is a $612,026 firm-fixed-price contract awarded by the Defense Advanced Research Projects Agency (DARPA) to 20N Labs, Inc., a self-certified small disadvantaged business. Under the contract, 20N Labs will design, build, and test molecules to make novel chemicals, demonstrating the viability of lab-in-the-cloud metabolic engineering. The contract does not have a set-aside designation and is scheduled for completion on September 9, 2016.</p>
This is a cost-plus-fixed-fee definitive contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Zyvex Labs, LLC, a for-profit limited liability company. The contract, valued at $8,919,897.00, is for atomic manufacturing and micron assembly services. The contract has an ultimate completion date of September 30, 2019 and does not have a set-aside designation. Zyvex Labs, LLC is a company that specializes in Atomically Precise Manufacturing (APM) and has received previous...
This is a $224,999 firm fixed-price contract awarded to Zymeron Corporation, a minority-owned small business, by the Defense Advanced Research Projects Agency (DARPA) under the Small Business Innovation Research (SBIR) Program Phase I. The contract is for the development of a lab-on-chip microfiltering and imaging device for rapid and automated sterility testing. This effort aligns with DARPA's mission to provide game-changing capabilities to the warfighter and its focus on leveraging small...
This is a $149,967.27 Small Business Innovation Research (SBIR) Phase I contract awarded by the Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense to Zymeron Corporation, a minority-owned small business. The contract supports research and development of innovative biotechnology solutions related to areas such as protein degradation, antibacterials, antivirals, and drug delivery systems. As a prime contractor, Zymeron has a history of providing medical...
This federal contract award, valued at $10,670,749.00, was issued by the Defense Advanced Research Projects Agency (DARPA) to Battelle Memorial Institute, a large nonprofit research and development organization, to develop the methodology for programming microbial sense-and-respond devices to reliably detect a variety of chemical and physical stimuli. The contract, known as the TELLUS program, aims to assess the feasibility of utilizing microbial devices for environmental monitoring purposes....
This is a $794,734 firm fixed-price definitive contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Phylagen, Inc. for the &quot;Biological Robustness in Complex Settings Program - Tracking Maritime Vessels through Microbiome Surveillance&quot; project. The contract has an ultimate completion date of September 4, 2017 and does not have a set-aside designation. The contract is focused on leveraging microbiome surveillance to track maritime vessels, which aligns with...
This is a $167,496.80 STTR Phase I contract awarded by the Department of the Army Materiel Command Research Development and Engineering Command to the minority-owned small business Zymeron Corporation. The contract is for research and development of innovative biotechnology solutions, including technologies related to protein degradation, antibacterials, antivirals, and drug delivery systems. Zymeron has experience providing medical research, engineering services, IT solutions, and biotech...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Tiny Farms Inc., a for-profit organization, for a project titled &quot;Screening Random Mutagenesis for Genetic Trait Mapping in Gryllodes sigillatus.&quot; The contract has a firm fixed price of $141,650.95 and a completion date of January 19, 2018. The contract is a definitive contract, which means it is a complete and final agreement between the parties. The...

Zymergen Inc. was awarded a $24.8 million other transaction agreement by the Defense Advanced Research Projects Agency to deliver on Task Area 2 of the LIVING FOUNDRIES: 1000 MOLECULES program. Under this effort, the Oakland, California-based company will leverage its synthetic biology capabilities to produce any microbe capable of manufacturing any target molecule. No set-aside designation was applied to this award. DARPA's LIVING FOUNDRIES initiative aims to develop a robust, scalable, and on-demand domestic biomanufacturing capability through engineering of novel biological systems. Zymergen will serve as the prime contractor to further the program's goal of synthesizing 1000 molecules of interest.

Generated 2/26/24, 9:36 AM